Abstract
Treatment with anti-tumour necrosis factor (TNF) is very effective in most patients with ankylosing spondylitis (AS), but inefficacy occurs in about 40% of cases.1 Antibody formation against TNF blocking agents...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have